Arcutis Biotherapeutics Inc

NASDAQ:ARQT   10:28:24 AM EDT
25.00
-0.15 (-0.60%)
Products

Arcutis To Host Investor Conference Call Today To Discuss The FDA Approval Of Zoryve (Roflumilast) Cream 0.3% For Plaque Psoriasis

Published: 08/01/2022 14:33 GMT
Arcutis Biotherapeutics Inc (ARQT) - Arcutis to Host Investor Conference Call Today to Discuss the FDA Approval of Zoryve™ (roflumilast) Cream 0.3% for Plaque Psoriasis.